FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology and radiology, and discloses a method for prediction of radiosensitivity of upper respiratory cancer. Method involves staining a suspension of biopsy cells using monoclonal antibodies to CD44, CD24, CD45 and DNA-binding dye Höchst33342, using flow cytometry, tumor stem cells with immunophenotype CD44+CD24-/low are detected, and their relative amount is determined among nucleated CD45-Höchst33342+ cells, then comparing the relative amount of tumor stem cells before and after irradiation in dose of 10 Gy, then by the change of this indicator, the degree of regression of the new growth is predicted under the effect of ionizing radiation.
EFFECT: proposed method provides more accurate assessment of indications for radiotherapy of patients suffering VAD cancer and can be used for prediction of individual radiosensitivity of upper respiratory malignancies at the initial stages of radiation and chemoradiation therapy.
1 cl, 5 ex, 5 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING RADIOSENSITIVITY OF AIRWAY CANCER | 2012 |
|
RU2505817C1 |
METHOD FOR SUPPRESSING THE INDUCING ACTION OF HIGH MOLECULAR WEIGHT HYALURONIC ACID ON BREAST CANCER STEM CELLS | 2021 |
|
RU2774031C1 |
METHOD OF INHIBITING RADIATION-INDUCED INCREASE IN HUMAN BREAST CANCER STEM CELLS | 2022 |
|
RU2800366C2 |
METHOD OF REDUCING THE NUMBER OF STEM CELLS OF HUMAN BREAST ADENOCARCINOMA | 2022 |
|
RU2798550C2 |
METHOD FOR REDUCING THE NUMBER OF STEM CELLS OF BREAST CANCER | 2018 |
|
RU2702910C2 |
METHOD FOR REDUCING CLONOGENIC ACTIVITY OF LACTEAL GLAND CANCER STEM CELLS | 2019 |
|
RU2700695C2 |
METHOD OF INCREASING THE EFFICIENCY OF PROTON THERAPY ON MELANOMA STEM CELLS | 2022 |
|
RU2798733C2 |
METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2020 |
|
RU2739294C1 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TARGETED THERAPY WITH CETUXIMAB IN THE PATIENTS SUFFERING SQUAMOUS CELL CARCINOMA OF THE TONGUE AND ORAL MUCOSA | 2019 |
|
RU2713453C1 |
Authors
Dates
2020-11-11—Published
2020-06-02—Filed